Jean-Jacques Gonvers
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Gonvers J, Troilliet N, Negro F, Monnat M, Malinverni R, Dutoit V, Dufour F, Chuard C, Chave J, Cerny A, Borovicka J, Bernasconi E, Genné D, Mullhaupt B, Cavassini M, Heim M, Oneta C. Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Med Wkly 2010; 140:w13055.
Jul 19, 2010Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Jul 19, 2010Swiss Med Wkly 2010; 140:w13055
Gonvers Jean-Jacques, Troilliet Nicolas, Negro Francesco, Monnat Martine, Malinverni Raffaelle, Dutoit Valérie, Dufour François, Chuard Christian, Chave Jean-Philippe, Cerny Andreas, Borovicka Jan, Bernasconi Enos, Genné Daniel, Mullhaupt Beat, Cavassini Matthias, Heim Markus H, Oneta Carl
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Ciuffreda D, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers J, Pantaleo G, Oneta C, Malinverni R, Comte D, Cavassini M, Giostra E, Buhler L, Perruchoud M, Heim M, Battegay M, Genné D, Mulhaupt B, Dutoit V. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. European journal of immunology 2008; 38:2665-77.
Oct 1, 2008Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Oct 1, 2008European journal of immunology 2008; 38:2665-77
Ciuffreda Donatella, Bernasconi Enos, Monnat Martine, Cerny Andreas, Chuard Christian, Borovicka Jan, Mentha Gilles, Pascual Manuel, Gonvers Jean-Jacques, Pantaleo Giuseppe, Oneta Carl, Malinverni Raffaele, Comte Denis, Cavassini Matthias, Giostra Emiliano, Buhler Leo, Perruchoud Monika, Heim Markus H, Battegay Manuel, Genné Daniel, Mulhaupt Beat, Dutoit Valérie
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Helbling B, Renner E, Meyer-Wyss B, Esteban A, Mullhaupt B, Dinges S, Wilhelmi M, Gonvers J, Borovicka J, Cerny A, Knöpfli M, Stamenic I, Jochum W, Swiss Association for the Study of the Liver (SASL). HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin. Journal of viral hepatitis 2006; 13:762-9.
Nov 1, 2006HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Nov 1, 2006Journal of viral hepatitis 2006; 13:762-9
Helbling Beat, Renner Eberhard L, Meyer-Wyss Beat, Esteban Alicia, Mullhaupt Beat, Dinges Sabine, Wilhelmi Martin, Gonvers Jean-Jacques, Borovicka Jan, Cerny Andreas, Knöpfli Marina, Stamenic Ivan, Jochum Wolfram, Swiss Association for the Study of the Liver (SASL)
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
August-Jörg B, Renner E, Weitz M, Meyenberger C, Hermann R, Henz S, Gonvers J, Dufour J, Borovicka J, Swiss Association for the Study of the Liver. Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:455-60.
Aug 23, 2003Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
Aug 23, 2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:455-60
August-Jörg Barbara S E, Renner Eberhard L, Weitz Manfred, Meyenberger Christa, Hermann Rudolf, Henz Samuel, Gonvers Jean-Jacques, Dufour Jean-François, Borovicka Jan, Swiss Association for the Study of the Liver
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial
Helbling B, Renner E, Sagmeister M, Borovicka J, Steuerwald M, Cathomas G, Reichen J, Dufour J, Gonvers J, Viani F, Stamenic I, Investigators of the Swiss Association for the Study of the Liver. Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial. Hepatology (Baltimore, Md.) 2002; 35:447-54.
Feb 1, 2002Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial
Feb 1, 2002Hepatology (Baltimore, Md.) 2002; 35:447-54
Helbling Beat, Renner Eberhard L, Sagmeister Markus, Borovicka Jan, Steuerwald Michael, Cathomas Gieri, Reichen Jurg, Dufour Jean-François, Gonvers Jean-Jacques, Viani Francesco, Stamenic Ivan, Investigators of the Swiss Association for the Study of the Liver